The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis

Seminars in Nuclear Medicine

Volumn 29, Issue 1, 1999, Pages 16-40

  Taillefer, R ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TECHNETIUM SULFUR COLLOID TC 99M; TETROFOSMIN TC 99M; THALLIUM CHLORIDE TL 201; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

BREAST CANCER; CANCER SCREENING; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; ISOTOPE LABELING; MAMMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTIMAMMOGRAPHY; BREAST TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M MEDRONATE; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032588222     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(99)80027-0     Document Type: Article

References (134)

1. Cancer facts and figures 1995 1995 American Cancer Society Atlanta, Georgia
2. Kopans DB The positive predictive value of mammography AJR 158 1992 521 526
3. Pollei SR Mettler FA Bartow SA Occult breast cancer: prevalence and radiographic detectability Radiology 163 1987 459 462
4. Bassett LW Liu TH Giuliano AE The prevalence of carcinoma in palpable versus impalpable, mammographically detected lesions AJR 157 1991 21 24
5. Tabar L Fagerberg CJ Duffy SW The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit J Epidemiol Community Health 43 1989 107 114
6. Sickles EA Mammographic features of early breast cancer AJR 143 1984 461 464
7. Niloff PH Sheiner NM False-negative mammograms in patients with breast cancer Can J Surg 24 1981 50 52
8. Meyer JE Sonnenfeld MR Greenes RA Preoperative localization of clinically occult breast lesions: experience at a referral hospital Radiology 169 1988 627 628
9. Mann BD Giuliano AE Bassett LW Delayed diagnosis of breast cancer as a result of normal mammograms Arch Surg 118 1983 23 25
10. Addler DD Whal RL New methods for imaging the breast: techniques, findings and potential AJR 164 1995 19 30
11. Low-Beer BVA Bell HG McCorkle HJ Measurement of radioactive phosphorus in breast tumors in situ: a possible diagnostic procedure Radiology 47 1946 492 493
12. Chapter 73 Taillefer R Breast Scintigraphy Murray Ell Nuclear Medicine in Clinical Diagnosis and Treatment Second Edition 1998 Churchill Livingstone publishers London
13. Major P Wang T Ishida M Breast cancer imaging with mouse monoclonal antibodies Eur J Nucl Med 15 1989 655 660
14. Lamki LM Buzdar AU Singletary SE Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study J Nucl Med 32 1991 1326 1332
15. Taylor JL Taylor DN Lowry C Radioimmunoscintigraphy of metastatic breast carcinoma Eur J Surg Oncology 18 1992 57 63
16. Rosner D Nabi H Wild L Diagnosis of breast carcinoma with radiolabeled monocolonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (MHFG) Cancer Investigation 13 1995 573 582
17. Williams MR Perkins AC Campbell FC The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast Clin Oncol 10 1984 375 381
18. Thor AD Edgerton SM Monoclonal antibodies reactive with human breast or ovarian carcinoma: in vivo applications Sem Nucl Med 29 1989 295 308
19. Bajc M Ingvar C Palmer J Dynamic indium-111-pentetreotide scintigraphy in breast cancer J Nucl Med 37 1996 622 626
20. VanEijck CHJ Krenning EP Bootsma A Somatostatin-receptor scintigraphy in primary breast cancer Lancet 343 1994 640 643
21. John CS Vilner BJ Gulden ME Synthesis and pharmacological characterization of 4-[125I]-N-(N-Benzylpiperidinyl)-4-iodobenzamide: a high affinity receptor ligand for potential imaging of breast cancer Cancer Res 55 1995 3022 3027
22. Symes EK Coulson WF Das R The synthesis of E-17-[131I]iodo-vinyl oestradiol and evaluation of its use as a radiotracer for oestrogen receptor positive breast tumours J Steroid Biochem 35 1990 641 646
23. Kenady DE Pavlik EJ Nelson K Images of estrogen receptor-positive breast tumors produced by estradiol labeled with iodine I 123 at 16 alpha Arch Surg 128 1993 1373 1381
24. DeRossi G Catino A Maini CL Tc-99m-DTPA breast scintigraphy: where does it stand? Radiol Diagn 19 1978 512 515
25. DenOuter AJ Pauwels EKJ Zwaveling A Breast scintigraphy with 99mTc-diethylene triamine penta-acetic acid for the detection of malignant disease Br J Surg 73 1986 613 616
26. Calandra JD Ryerson TW Cahill E Uptake of technetium-99m sulfur colloid by a breast carcinoma Clin Nucl Med 15 1990 432 433
27. Jing JM Kim EE Moulopoulos L Primary breast lymphoma detected with SPECT using Gallium-67-citrate J Nucl Med 36 1995 236 237
28. Mintun MA Welch MJ Siegel BA Breast cancer: PET imaging of estrogen receptors Radiology 169 1988 45 48
29. Minn H Soini I [18F] Fluorodeoxyglucose scintigraphy in diagnosis and follow-up of treatment in advance breast cancer Eur J Nucl Med 15 1989 61 66
30. Dehdashti F McGuire AH VanBrocklin HF Assessment of 21-[18F] Fluoro-16-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas J Nucl Med 32 1991 1532 1537
31. Nieweg OE Kim EE Wong WH Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer Cancer 71 1993 3920 3925
32. Bassa P Kim EE Inoue T Evaluation of preoperative chemotherapy using PET with Fluorine-18-Fluorodeoxyglycose in breast cancer J Nucl Med 37 1996 931 938
33. Hisada K Tonamin N Miyamae T Clinical evaluation of tumor imaging with thallium-201 chloride Radiology 129 1978 497 500
34. Sluyser M Hoefnagel C Breast carcinomas detected by thallium-201 scintigraphy Cancer Letter 40 1988 161 168
35. Sehweil AM McKillop JH Milroy R Mechanism of 201 T1 uptake in tumours Eur J Nucl Med 15 1989 376 379
36. Sehweil AM McKillop JH Milroy R 201T1 scintigraphy in the staging of lung cancer, breast cancer and lymphoma Nu Med Comm 11 1990 263 269
37. Waxman AD Ramanna L Memsic LD Thallium scintigraphy in the evaluation of mass abnormalities of the breast J Nucl Med 34 1993 18 23
38. Lee VW Sac EJ McAneny DB A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer J Nucl Med 34 1993 2095 2100
39. Rebollo AC Torres-Avisbal M Espinosa JE Evaluation of palpable breast masses with 201T1 scintigraphy Brit J Radiol 68 1995 1052 1057
40. Cimitan M Volpe R Candiani E The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography Eur J Nucl Med 22 1995 1110 1117
41. Muller ST Guth-Tougelids B Creutzig GH Imaging of malignant tumors with Tc-99m MIBI SPECT Eur J Nucl Med 28 1987 562
42. Hassan IM Sehweil A Constantinindes C Uptake and kinetics of Tc-99m hexakis 2-methoxy-isobutyl isonitrile in benign and malignant lesions in the lungs Clin Nucl Med 14 1989 333 340
43. Aktolun C Bayhan H Kir M Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors: preliminary results and comparison with T1-201 Clin Nucl Med 17 1992 171 176
44. Chiu ML Kronange JF Piwnica-Worms D Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2 methoxy-isobutyl isonitrile) technetium in cultured mouse fibroblasts J Nucl Med 31 1990 1646 1653
45. Delmon-Moingeon LI Piwnica-Worms D Van Ven Abbeele AD Uptake of the cation hexakis (2-methoxy isobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro Cancer Res 50 1990 2148 2202
46. Piwnica-Worms D Chiu ML Budding M Functional imaging of multidrug resistant P-glycoprotein with an organotechnetium complex Cancer Res 53 1993 977 984
47. Cordobes MD Strazec A Delmon-Moingeon L Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression J Nucl Med 37 1996 286 289
48. Moretti JL Azaloux H Boisseron D Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein over expression Eur J Nucl Med 23 1996 980 986
49. Cwikla JB Buscombe JR Barlow RV The effect of Eur J Nucl Med 24 1997 1175 1178
50. Del Vecchio S Ciarmiello A Pace L Fractional Retention of Technetium-99m-Sestamibi as an Index of P-Glycoprotein Expression in Untreated Breast Cancer Patients J Nucl Med 38 1997 1348 1351
51. Del Vecchio S Ciarmiello A Potena MI In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients Eur J Nucl Med 24 1997 150 159
52. Kostakoglu L Elahi N Kiratli P Clinical Validation of the Influence of P-Glycoprotein on Technetium-99m-Sestamibi Uptake in Malignant Tumors J Nucl Med 38 1997 1003 1008
53. Luker GD Fracasso PM Dobkin J Modulation of the Multidrug Resistance P-Glycoprotein: Detection with Technetium-99m-Sestamibi In Vivo J Nucl Med 38 1997 369 372
54. Piwnica-Worms D Luker G Fracasso P Dobkin J Detection of MDR with Tc99m sestamibi J Nucl Med 38 1997 369 372
55. Tachibana A Correlations of Accumulation of Tc-99m Methoxy Isobutyl Isonitrile (99mTc-sestamibi), Antitumorigenic Effects of Anticarcinogenic Agents and Expression of P-Glycoprotein Teikyo Medical Journal 19 1996 153 162
56. Crane PD Onthank DC Bourque CR Autoradiography and radioscintigraphy of technetium-99m-sestamibi in c-neu transgenic mice J Nucl Med 36 1995 1862 1868
57. Maublant J Zheng Z Rapp M In vitro uptake of Tc-99m Teboroxime in carcinoma cell lines and normal cell lines: comparison with Tc-99m sestamibi and T1-201 J Nucl Med 34 1993 1949 1952
58. Omar WS Eissa S Moustafa H Role of Thallium-201 Chloride and Tc-99m Methoxy-Isobutyl-Isonitrile (sestaMIBI) in Evaluation of Breast Masses: Correlation with the Immunohistochemical Characteristic Parameters (Ki-67, PCNA, BcI-2, and Angiogenesis) in Malignant Lesions Anticancer Research 17 1997 1639 1644
59. Scopinaro F Schillaci O Scarpini M Technetium-99m Sestamibi: an indicator of breast cancer invasiveness Eur J Nucl 21 1994 984 987
60. Mangkharak J Patanachak C Podhisuwan K The Evaluation of Combined scintimammography and Tumor Markers in Breast Cancer Patients Anticancer Research 17 1997 1611 1614
61. Maurer AH Caroline DF Jadali FJ Limitations of craniocaudal Thallium-201 and Technetium99m-Sestamibi mammoscintigraphy J Nucl Med 36 1995 1696 1700
62. A. Diggles L Mena I Khalkhali I Technical Aspects of Prone Dependent-Breast Scintimammography J Nucl Med Technol 22 1994 165 170
63. Pani R Scopinaro F Pellegrini R The Role of Compton Background and Breast Compression on Cancer Detection in Scintimammography Anticancer Research 17 1997 1645 1650
64. Taillefer R Robidoux A Lambert R Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement J Nucl Med 36 1995 1758 1765
65. Khalkhali I Mena I Jouanne E Prone scintimammography in patients with suspicion of carcinoma of the breast J Am Coll Surg 178 1994 491 497
66. Lu G Shih WJ Huang HY 99mTc-MIBI mammoscintigraphy of breast masses: early and delayed imaging Nucl Med Commun 16 1995 150 156
67. Nagaraj N Waxman A Ashok G Comparison of SPECT and planar Tc-99m sestamibi (MIBI) imaging in patients with carcinoma of the breast J Nucl Med 35 1994 229
68. Palmedo H Schomburg A Grunwald F Technetium-99m-MIBI scintimammography for suspicious breast lesions J Nucl Med 37 1996 626 630
69. Becherer A Helbich T Staudenherz A The diagnostic value of planar and SPET scintimammography in different age groups Nucl Med Comm 18 1997 710 718
70. Waxman AD The role of 99mTc methoxyisobutylisonitrile in imaging breast cancer Semin Nucl Med 27 1997 40 54
71. Burak Z Argon M Memis A Evaluation of palpable breast masses with 99mTc-MIBI: a comparative study with mammography and ultrasonography Nucl Med Commun 15 1994 604 612
72. Kao C Wang S Liu T The use of Tc99m methoxybutylisonitrile breast scintigraphy to evaluate palpable breast masses Eur J Nucl Med 21 1994 432 436
73. Khalkhali I Cutrone JA Mena IG Scintimammography: the complementary role of Tc99m sestamibi prone breast imaging for the diagnosis of breast carcinoma Radiology 196 1995 421 426
74. Khalkhali I Cutrone J Mena I Technetium-99m-Sestamibi Scintimammography of Breast Lesions: Clinical and Pathological Follow-up J Nucl Med 36 1995 1784 1789
75. Villanueva-Meyer J Leonard MH Jr Briscoe LJE Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer J Nucl Med 37 1996 926 930
76. Palmedo H Schomburg A Grunwald F Scintimammography with Tc-99m MIBI in Patients with Suspicion of Primary Breast Cancer Nucl Med Biol 23 1996 681 684
77. Maffioli L Agresti R Chiti A Prone scintimammography in patients with nonpalpable breast lesions Anticancer Res 16 1996 1269 1273
78. Clifford EJ Lugo-Zamudio C Scintimammography in the Diagnosis of Breast Cancer Am J Surg 172 1996 483 486
79. Carril JM Gomez-Barquin R Quirce R Contribution of 99mTc-MIBI Scintimammography to the Diagnosis of Non-Palpable Breast Lesions in Relation to Mammographic Probability of Malignancy Anticancer Research 17 1997 1677 1681
80. Buscombe JR Cwikla JB Thakrar DS Uptake of Tc-99m MIBI related to tumor size and type Anticancer Research 17 1997 1693 1694
81. Ambrus E Rajtar M Ormandi K Value of 99mTc MIBI and 99mTc(V) DMSA Scintigraphy in Evaluation of Breast Mass lesions Anticancer Research 17 1997 1599 1605
82. Chen SL Yin YQ Chen JX The Usefulness of Technetium-99m-MIBI Scintimammography in Diagnosis of Breast Cancer: Using Surgical Histopathologic Diagnosis as the Gold Standard Anticancer Research 27 1997 1695 1998
83. Scopinaro F Schillaci O Ussof W A Three Center Study on the Diagnostic Accuracy of 99mTc-MIBI Scintimammography Anticancer Research 17 1997 1631 1634
84. Scopinaro F Ierardi M Porfiri LM 99mTc-MIBI Prone Scintimammography in Patients with High and Intermediate Risk Mammography Anticancer Research 17 1997 1635 1638
85. Tiling R Khalkhali I Sommer H Role of technetium-99m sestamibi scintimammography and contrast-enhanced magnetic resonance imaging for the evaluation of indeterminate mammograms Eur J Nucl Med 24 1997 1221
86. Helbich TH Becherer A Trattnig S Differentiation of Benign and Malignant Breast Lesions: MR Imaging versus Tc-99m Sestamibi Scintimammography Radiology 202 1997 421 429
87. Collela AC Scopinaro F Schillaci O 99mTc-Sestamibi Breast Scintigraphy Tumori 83 1997 520 522
88. Mekhmandarov S Sandbank J Cohen M Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions J Nucl Med 39 1998 86 91
89. Palmedo H Grunwald F Bender H Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging Eur J Nucl Med 23 1996 940 946
90. Palmedo H Bender H Grunwald F Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumors Eur J Nucl Med 24 1997 1138 1145
91. Campeau RJ Kronemer KA Sutherland CM Concordant uptake of Tc-99m sestamibi and T1-201 in unsuspected breast tumor Clin Nucl Med 12 1992 936 937
92. Chiti A Maffioli L Castellani M Case report: technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile imaging of breast cancer and myocardial infarction in the same patient Tumori 6 1994 480 481
93. Vicioso Jiménez A Mañas Moreño E Delgado Carreras J Breast scintigraphy with 99mTc-MIBI in the evaluation of tumor pathology: preliminary results Rev Esp Med Nucl 13 1994 269 274
94. Omar AM Higazy E Hussein S Abnormal extra cardiac uptake of 99mTc sestamibi, accidental findings in myocardial perfusion tomography Radiologia diagnostica 34 1993 364 365
95. 18F-FDG be considered as the best method? International J Oncol 8 1996 693 699
96. Kao CH Wang SJ Yeh SH Tc-99m MIBI Uptake in Breast Carcinoma and Axillary Lymph Node Metastases Clin Nucl Med 19 1994 898 900
97. Tiling R Sommer H Pechmann M Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions J Nucl Med 38 1997 58 62
98. Alazraki NP Eshima D Eshima LA Lymphoscintigraphy, the Sentinel Node concept and the Intraoperative Gamma Probe in Melanoma, Breast Cancer, and Other Potential Cancers Sem Nucl Med 27 1997 55 67
99. Maublant J de Latour M Mestas D Technetium-99m-Sestamibi Uptake in Breast Tumor and Associated Lymphnodes J Nucl Med 37 1996 922 925
100. Lam WWM Yang WT Chan YL Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammography Eur J Nucl Med 23 1996 498 503
101. Lam WWM Yang WT Chan YL Role of MIBI breast scintigraphy in evaluation of palpable breast lesions Br J Radiol 69 1996 1152 1158
102. Schillaci O Scopinaro F Danieli R Technetium-99m Sestamibi Imaging in the Detection of Axillary Lymph Node Involvement in Patients with Breast Cancer Anticancer Research 17 1997 1607 1610
103. Perre CI Rutter JE Vos PAFM Technetium-99m-sestamibi uptake in axillary lymph node metastases in breast cancer patients Eur J Surg Oncol 23 1997 142 144
104. 111In-Pentetreotide Tumori 83 1997 537 538
105. Taillefer R Robidoux A Turpin S Metastatic Axillary Lymph Node Technetium-99m-MIBI Imaging in Primary Breast Cancer J Nucl Med 39 1998 459 464
106. Rambaldi PF Mansi L Procaccini E Breast cancer detection with Tc-99m Tetrofosmin Clin Nucl Med 20 1995 703 705
107. Younes A Songadele JA Maublant J Mechanism of uptake of technetium-tetrofosmin. II. Uptake into isolated adult rat heart mitochondria J Nucl Cardiol 2 1995 327 332
108. Arbab AS Koizumi K Toyama K Uptake of technetium-99m tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines J Nucl Med 37 1996 1551 1556
109. Ballinger JR Banneman J Boxen I Tc-99m-Tetrofosmin as a substrate for p-glycoprotein: in vivo studies in multidrug-resistant breast tumor cells J Nucl Med 37 1996 1578 1581
110. Wolf H Frieling B Nacke C Tc-99m Tetrofosmin accumulation in sensitive and multidrug resistant tumor cells with and without verapamil Eur J Nucl Med 23 1996 1095
111. DeJong M Bernard BF Freeman WAP Comparison of uptake of 99mTc-MIBI, 99mTc-Tetrofosmin and 99mTc-Q12 into human breast cancer cell line Eur J Nucl Med 23 1996 1361 1366
112. Chapter 11 Mansi L Rambaldi PF Cuccurullo V Breast imaging with 99mTc-Tetrofosmin Taillefer R Khalkhali I Waxman A Biersack H Radionuclide Imaging of the Breast 1998 Marcel Dekker Inc publishers New York 339 367
113. Mansi L Rambaldi PF Procaccini E Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases Eur J Nucl Med 23 1996 932 939
114. Batista JF Solano ME Oliva JP Usefulness of 99mTc-Tetrofosmin scintimammography in palpable breast tumors Nucl Med Comm 18 1997 338 340
115. m-tetrofosmin scintigraphy in the evaluation of palpable breast masses Nucl Med Comm 18 1997 118 121
116. Fenlon HM Phelan NC O'Sullivan P Benign versus Malignant Breast Disease: Comparison of Contrast-enhanced MR Imaging and Tc-99m Tetrofosmin Scintimammography Radiology 205 1997 214 220
117. Madariaga P Almoguera I Alonso A Technetium-99m Tetrofosmin Scintigraphy to Evaluate Breast Lesion Anticancer Research 27 1997 1619 1622
118. Schillaci O Scopinaro F Danieli R Scintimammography with Technetium-99m Tetrofosmin in Suspected Breast Cancer Anticancer Research 17 1997 1623 1626
119. Lind P Umschaden HW Forsthuber E Scintimammography using Tc-99m Tetrofosmin Acta Med Austrica 24 1997 50 54
120. Subramanian G McAfee JG Blair AJ Technetium-99m methylene diphosphonate a superior agent for skeletal imaging: comparison with other technetium complexes J Nucl Med 16 1975 744 755
121. Berg JR Kalisher L Osmond JD Technetium-99m-diphosphonate concentration in primary breast cancer Radiology 109 1973 393 394
122. Chauduri TK Gulesserian HP Christie TH Extraoseous noncalcified soft-tissue uptake of 99mTc-polyphosphate J Nucl Med 15 1974 1054 1056
123. Worsley DF Lentle BC Uptake of technetium-99m-MDP in primary amyloidosis with a review of the mechanisms of soft-tissue localization of bone-seeking radiopharmaceuticals J Nucl Med 34 1993 1612 1615
124. Maffioli L Seregui E Chiti A Radiopharmaceuticals for breast cancer imaging Tumori 83 1997 512 514
125. Chapter 9 Lastoria S Piccolo S Muto P Breast imaging with 99mTc-methylene diphosphonate Taillefer R Khalkhali I Waxman A Biersack H Radionuclide Imaging of the Breast 1998 Marcel Dekker Inc publishers New York 299 323
126. Piccolo S Lastoria S Mainolfi C Technetium-99m methylene diphosphanate scintimammography to image primary breast cancer J Nucl Med 36 1995 718 724
127. Piccolo S Lastoria S Muto P Scintimammography (SMM) with 99m Tc-MDP: an overview of the experience at the National Cancer Institute of Napoli Tumori 83 1997 515 519
128. Maini CL Tofani A Schiuto R Technetium-99m-MIBI scintimammography in the Assessment of Neoadjuvant Chemotherapy in Breast Carcinoma J Nucl Med 38 1997 1546 1551
129. Hibbeln JF Blend MJ Wood DK Tc-99m Sestamibi Uptake in Infiltrating Ductal Carcinoma of the Breast in a Male Patient Clin Nucl Med 21 1996 469 470
130. Ohta H Kosumi T Kitai T Three patients with bilateral breast tumors examined by technetium-99m-sestamibi scintimammography Ann Nucl Med 11 1997 259 262
131. De Vincentis G Scopinaro F Pani R 99mTc MIBI Scintimammography with a High Resolution Single Tube Gamma Camera: Preliminary Study Anticancer Research 17 1997 1627 1630
132. Khalkhali I Mishkin FS Diggles LE Radionuclide-guided stereotactic prebiopsy localization of nonpalpable breast lesions with normal mammograms J Nucl Med 38 1997 1019 1022
133. Cox CE Hiacinthe M Berman C Localization of an occult primary breast cancer with technetium-99m sestamibi scan and an intraoperative gamma probe Cancer Control 3 1996 448 450
134. Hillner BE Decision analysis: MIBI imaging of non palpable breast abnormalities J Nucl Med 38 1997 1772 1778